Literature DB >> 28652111

Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro.

Elizabeth S Robinson1, Paul Alves1, Muhammad M Bashir1, Majid Zeidi1, Rui Feng2, Victoria P Werth3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28652111      PMCID： PMC5651184          DOI： 10.1016/j.jid.2017.05.035

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  12 in total

1.  Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.

Authors:  Mark A Tepper; Robert B Zurier; Sumner H Burstein
Journal:  Bioorg Med Chem       Date:  2014-05-09       Impact factor: 3.641

2.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.

Authors:  L M Pachman; M R Liotta-Davis; D K Hong; T R Kinsella; E P Mendez; J M Kinder; E H Chen
Journal:  Arthritis Rheum       Date:  2000-10

3.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

4.  Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells.

Authors:  Judith A Stebulis; David R Johnson; Ronald G Rossetti; Sumner H Burstein; Robert B Zurier
Journal:  Life Sci       Date:  2008-09-21       Impact factor: 5.037

5.  Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.

Authors:  Robert B Zurier; Yee-Ping Sun; Kerri L George; Judith A Stebulis; Ronald G Rossetti; Ann Skulas; Erica Judge; Charles N Serhan
Journal:  FASEB J       Date:  2009-01-05       Impact factor: 5.191

6.  Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid.

Authors:  Robert B Zurier; Ronald G Rossetti; Sumner H Burstein; Bonnie Bidinger
Journal:  Biochem Pharmacol       Date:  2003-02-15       Impact factor: 5.858

7.  Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.

Authors:  Jennifer Parker; Francisco Atez; Ronald G Rossetti; Ann Skulas; Rakesh Patel; Robert B Zurier
Journal:  Rheumatol Int       Date:  2007-11-27       Impact factor: 2.631

8.  Cannabinoid-receptor expression in human leukocytes.

Authors:  M Bouaboula; M Rinaldi; P Carayon; C Carillon; B Delpech; D Shire; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1993-05-15

9.  Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.

Authors:  Adam S Nabatian; Muhammad M Bashir; Maria Wysocka; Meena Sharma; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2012-01-04       Impact factor: 5.156

10.  Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors:  Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2012-03-29       Impact factor: 8.551
View more
  12 in total

Review 1.  Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.

Authors:  Kristen L Chen; Majid Zeidi; Victoria P Werth
Journal:  Curr Rheumatol Rep       Date:  2019-08-31       Impact factor: 4.592

2.  Itch in dermatomyositis: the role of increased skin interleukin-31.

Authors:  H J Kim; M Zeidi; D Bonciani; S M Pena; J Tiao; S Sahu; V P Werth
Journal:  Br J Dermatol       Date:  2018-06-21       Impact factor: 9.302

Review 3.  Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Authors:  Amber Cintosun; Irene Lara-Corrales; Elena Pope
Journal:  Clin Drug Investig       Date:  2020-04       Impact factor: 2.859

4.  Thymoquinone reduces ischemia and reperfusion-induced intestinal injury in rats, through anti-oxidative and anti-inflammatory effects.

Authors:  Ali Parlar; Seyfullah Oktay Arslan
Journal:  Turk J Surg       Date:  2020-03-18

Review 5.  Pruritus in autoimmune connective tissue diseases.

Authors:  Hee Joo Kim
Journal:  Ann Transl Med       Date:  2021-03

6.  Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.

Authors:  Spandana Maddukuri; Jay Patel; De Anna Diaz; Kristen L Chen; Maria Wysocka; Christina Bax; Yubin Li; Adarsh Ravishankar; Madison Grinnell; Majid Zeidi; Nithin Reddy; Josef Symon S Concha; Muhammad M Bashir; Joyce Okawa; Barbara White; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2022-01-04       Impact factor: 5.606

Review 7.  TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease.

Authors:  Aislinn D Maguire; John R Bethea; Bradley J Kerr
Journal:  Front Neurol       Date:  2021-12-06       Impact factor: 4.003

Review 8.  Ajulemic acid: potential treatment for chronic inflammation.

Authors:  Sumner H Burstein
Journal:  Pharmacol Res Perspect       Date:  2018-04

Review 9.  Cannabinoids in the Pathophysiology of Skin Inflammation.

Authors:  Cristian Scheau; Ioana Anca Badarau; Livia-Gratiela Mihai; Andreea-Elena Scheau; Daniel Octavian Costache; Carolina Constantin; Daniela Calina; Constantin Caruntu; Raluca Simona Costache; Ana Caruntu
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.927

Review 10.  Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier.

Authors:  Cristian Scheau; Constantin Caruntu; Ioana Anca Badarau; Andreea-Elena Scheau; Anca Oana Docea; Daniela Calina; Ana Caruntu
Journal:  J Pers Med       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.